For individuals with Crohn's disease, these side effects may complicate symptom assessment and make it difficult to determine whether gastrointestinal symptoms are due to the medication, a disease flare, or both
Current protocols recommend treating patients with an initial dose of 150 mg/kg NAC, infused over a period of an hour, upon hospitalization, followed by decreasing amounts of NAC infused over the next 20 hours[1]
Phase 4: the 1.7mg acceleration dose (34 units) The jump from 1.0mg to 1.7mg is the largest single escalation in the standard protocol, a 0.7mg increase compared to the 0.25mg and 0.5mg jumps earlier
Thus, the enzymatic reduction of roGFP2(S 2 ) by GSH follows monothiol mechanism (iii) and requires a glutaredoxin to form roGFP2(SSG)
Denials at this stage are common but not final
There are some which prevent digestive enzymes from working on carbs